FEATURE HKUMed’s globally-leading response to the COVID-19 pandemic saw our experts achieve many firsts in describing the disease and providing solutions. Now, as borders have re-opened and the pandemic has abated, the focus is turning back to other conditions and diseases where the Faculty excels, such as cancer research, viral hepatitis, cardiometabolic disease and stem cells, etc. and to those where there is potential for future impact, such as neuroscience and precision medicine. Fortunately, this is all coinciding with unprecedented expansion and investment in HKUMed’s development, which are equipping us for the next big challenges. ‘When COVID-19 arrived, we were able to respond very quickly because of our past track record and experience. We contributed a lot of important findings from microbiology, virology, public health, clinical research and big data because everyone focused and worked on this problem,’ said Professor Leung Wai-keung, Associate Dean (Research). ‘That same attitude and preparation can be tapped to make big impacts in other areas, too. It is time to bring that attention back to our other strengths and find new areas to develop.’ Advancing from an enviable position, HKUMed has jumped to 31st position in the 2023 Quacquarelli Symonds (QS) World University Rankings in the subject of Medicine, moving up nine places from 40th last year, and is the top-ranked medical school in Hong Kong. HKUMed also leapt 20 places in the subject of Life Sciences and Medicine, moving from 49th THE WUR by Subject in Clinical and Health (2023) QS WUR by Subject in Medicine (2023) New Peaks on The Horizon 1st in HK 1st in HK 13th Worldwide 31st Worldwide 6
RkJQdWJsaXNoZXIy Mzg4NDg0